20B

Biomark Diagnostics
20B

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€21.86M
EV
€20.98M
Shares Outstanding
105.09M
Beta
-0.44

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2026E
-
P/Revenue 2026E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biomark Diagnostics Inc.

gainify
20B

Biomark Diagnostics Inc.

20B

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partne...

Sector

Industry

CEO

Bux, Rashid Ahmed

Employees

IPO Date

Headquarters

3851 Shell Road, Suite 130, Richmond, British Columbia, V6X 2W2, Canada

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.